Nitrol (Mitoxantrone) 20mg/10ml

Nitrol (Mitoxantrone 20mg/10ml) is a prescription chemotherapy medication used to treat certain cancers and multiple sclerosis. This sterile injectable solution is administered under medical supervision. Always consult a healthcare professional for proper use and dosing.

Strength

20mg/10ml

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mitoxantrone 20mg/10ml is primarily used to treat aggressive forms of multiple sclerosis and certain types of cancer, including leukemia and prostate cancer. It belongs to a class of drugs known as anthracyclines, which work by slowing or stopping cancer cell growth. Patients often ask, 'what is Mitoxantrone used for' in managing relapsing-remitting MS or as part of chemotherapy regimens.

Side Effects

Mitoxantrone may cause temporary blue-green discoloration of urine, skin, or whites of the eyes, which is harmless but noticeable. Some patients report mild nausea or fatigue shortly after administration, though these effects vary by individual. Hair thinning is possible but not universal. Always report unexpected reactions to your healthcare provider.

Precautions & Warnings

This medication should only be handled and administered by trained medical professionals in a clinical setting. Patients with liver problems or heart conditions may need adjusted dosing or closer monitoring. Avoid pregnancy during treatment and for several months afterward. Keep this medication refrigerated and protected from light until use.

Avoid Interactions

Mitoxantrone can interact with other chemotherapy drugs, blood thinners, or medications affecting liver enzymes. Alcohol may increase side effects like nausea or dizziness. Live vaccines should be avoided during treatment. Always inform your doctor about all medications, supplements, or herbal products you are using.

Frequently Asked Questions

It is prescribed for certain cancers and aggressive multiple sclerosis to slow disease progression.

It is given as an intravenous infusion by healthcare professionals in a controlled setting.

Some patients experience dizziness or fatigue; avoid driving until you know how the medication affects you.

Hair thinning is a possible side effect, though not everyone experiences it.

It is not recommended during pregnancy due to potential risks to the fetus.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.